NUVB Competitors & Alternatives
Compare Nuvation Bio Inc with similar stocks in the same industry
Biotechnology
NUVB
Main Stock$4.72
Tradestie Score
63
Market Cap
$1.27B
Revenue Growth
26.0%
Analyst Upside
+161.3%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$31.27
|
$1.84B | - | 52 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.65
|
$1.81B | - | 60 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.72
|
$1.78B | - | 59 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.99
|
$1.78B | - | 58 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$16.35
|
$1.74B | - | 53 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$29.77
|
$1.68B | - | 55 | Compare |
|
MNKD
Mannkind Corporation
|
$3.36
|
$1.65B | - | 58 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$36.21
|
$1.63B | - | 61 | Compare |
|
BHVN
Biohaven Ltd.
|
$10.81
|
$1.57B | - | 55 | Compare |
|
VCEL
Vericel Corporation
|
$34.74
|
$1.56B | 80.1 | 60 | Compare |
More NUVB Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry